Zentalis Pharmaceuticals (NASDAQ:ZNTL) Sets New 12-Month Low at $9.48

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as $9.48 and last traded at $9.59, with a volume of 536323 shares changing hands. The stock had previously closed at $9.99. Wall Street Analyst Weigh In A number of research firms recently weighed […]

Related Keywords

Diana Hausman ,Stifel Nicolaus ,Zentalis Pharmaceuticals Inc ,News Ratings For Zentalis Pharmaceuticals Daily ,Zentalis Pharmaceuticals Company Profile ,Nasdaq ,Decheng Capital ,Vanguard Group Inc ,Pricet Rowe Associates Inc ,Zentalis Pharmaceuticals Stock Down ,Institutional Trading Of Zentalis Pharmaceuticals ,Hermes Inc ,Zentalis Pharmaceuticals ,Eventide Asset Management ,Get Free Report ,Pharmaceuticals Stock Down ,Asset Management ,Federated Hermes ,Zentalis Pharmaceuticals Daily ,